POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 69 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,648,000 | -53.9% | 750,000 | -4.8% | 0.08% | -7.2% |
| Q3 2021 | $5,743,000 | -63.6% | 787,745 | -50.0% | 0.08% | -19.4% |
| Q2 2021 | $15,786,000 | +109.8% | 1,575,490 | +100.0% | 0.10% | +8.4% |
| Q1 2021 | $7,523,000 | -12.9% | 787,745 | 0.0% | 0.10% | +2.2% |
| Q4 2020 | $8,642,000 | +23.7% | 787,745 | 0.0% | 0.09% | -8.8% |
| Q3 2020 | $6,987,000 | – | 787,745 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 3,567,985 | $8,491,804 | 2.58% |
| Aisling Capital Management LP | 1,043,267 | $2,482,975 | 1.02% |
| Atom Investors LP | 156,168 | $371,680 | 0.08% |
| Pentwater Capital Management LP | 5,975,000 | $14,220,500 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 79,709 | $189,707 | 0.04% |
| Forefront Analytics, LLC | 24,969 | $59,428 | 0.03% |
| Callan Capital, LLC | 76,559 | $182,210 | 0.02% |
| XTX Topco Ltd | 40,782 | $97,061 | 0.02% |
| Advisory Services Network, LLC | 257,271 | $612,305 | 0.02% |
| RBF Capital, LLC | 70,171 | $167,007 | 0.01% |